Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic Use
- PMID: 27462384
- PMCID: PMC4898580
Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic Use
Abstract
Oral and topical antibiotics are commonly prescribed in dermatologie practice, often for noninfectious disorders, such as acne vulgaris and rosacea. Concerns related to antibiotic exposure from both medical and nonmedical sources require that clinicians consider in each case why and how antibiotics are being used and to make appropriate adjustments to limit antibiotic exposure whenever possible. This first article of a three-part series discusses prescribing patterns in dermatology, provides an overview of sources of antibiotic exposure, reviews the relative correlations between the magnitude of antibiotic consumption and emergence of antibiotic resistance patterns, evaluates the impact of alterations in antibiotic prescribing, and discusses the potential relevance and clinical sequelae of antibiotic use, with emphasis on how antibiotics are used in dermatology.
Similar articles
-
Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology.J Clin Aesthet Dermatol. 2016 Jun;9(6):17-24. Epub 2016 Jun 1. J Clin Aesthet Dermatol. 2016. PMID: 27386047 Free PMC article.
-
Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists.Cutis. 2008 Aug;82(2 Suppl 2):5-12. Cutis. 2008. PMID: 18924545 Review.
-
Topical antibiotic monotherapy prescribing practices in acne vulgaris.J Dermatolog Treat. 2014 Apr;25(2):97-9. doi: 10.3109/09546634.2013.852297. J Dermatolog Treat. 2014. PMID: 24171409
-
New antibiotic therapies for acne and rosacea.Dermatol Ther. 2012 Jan-Feb;25(1):23-37. doi: 10.1111/j.1529-8019.2012.01497.x. Dermatol Ther. 2012. PMID: 22591497
-
The Clinical Relevance of Antibiotic Resistance: Thirteen Principles That Every Dermatologist Needs to Consider When Prescribing Antibiotic Therapy.Dermatol Clin. 2016 Apr;34(2):167-73. doi: 10.1016/j.det.2015.12.003. Dermatol Clin. 2016. PMID: 27015776 Review.
Cited by
-
Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology.J Clin Aesthet Dermatol. 2016 Jun;9(6):17-24. Epub 2016 Jun 1. J Clin Aesthet Dermatol. 2016. PMID: 27386047 Free PMC article.
-
A Retrospective Review of a Cohort of Patients with Periorificial Dermatitis Treated with Sarecycline.J Clin Aesthet Dermatol. 2024 Jun;17(6):50-54. J Clin Aesthet Dermatol. 2024. PMID: 38912196 Free PMC article.
-
Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation.Antibiotics (Basel). 2021 Apr 15;10(4):439. doi: 10.3390/antibiotics10040439. Antibiotics (Basel). 2021. PMID: 33920812 Free PMC article. Review.
-
Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.Antibiotics (Basel). 2022 May 27;11(6):722. doi: 10.3390/antibiotics11060722. Antibiotics (Basel). 2022. PMID: 35740129 Free PMC article.
-
Criticality of Benzoyl Peroxide and Antibiotic Fixed Combinations in Combating Rising Resistance in Cutibacterium acnes.Clin Cosmet Investig Dermatol. 2025 Mar 31;18:755-766. doi: 10.2147/CCID.S506254. eCollection 2025. Clin Cosmet Investig Dermatol. 2025. PMID: 40190474 Free PMC article.
References
-
- Kim S, Michaels BD, Kim GK, Del Rosso JQ. Systemic antibacterial agents. In: Wolverton SE, editor. Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: Elsevier-Saunders; 2013. pp. 61–97. 3rd ed.
-
- Bhatia N. Use of antibiotics for noninfectious dermatologic disorders. Dermatol Clin. 2009;27(1):85–89. - PubMed
-
- GoUnick H, Cunliffe W, Berson D, et al. Management of acne: report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(1):S1–S37. - PubMed
-
- Del Rosso JQ. Report from the scientific panel on antibiotic use in dermatology: introduction. Cutis. 2007;79(6S):6–8. - PubMed
-
- Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007;79(suppl 6):9–25. - PubMed